Clinical Trial Update: Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System

View source ↗

Summary

An ancillary analysis of the Gynecologic Oncology Group 158 trial evaluating survival outcomes when tumors are reclassified under a two-tier grading system in o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Status: COMPLETED